Johnson & Johnson executives repeatedly told analysts that J&J expects to share results from its late-stage study of its experimental COVID-19 vaccine—the first requiring only one dose—"by early next week."
from J&J 4Q sales rise despite pandemic, but charges cut profits
https://ift.tt/3ps4VKQ
https://ift.tt/eA8V8J
No comments:
Post a Comment